Stay updated on GVAX & Pembrolizumab in MMR-p CRC Clinical Trial
Sign up to get notified when there's something new on the GVAX & Pembrolizumab in MMR-p CRC Clinical Trial page.

Latest updates to the GVAX & Pembrolizumab in MMR-p CRC Clinical Trial page
- Check4 days agoChange DetectedRevision label updated from v3.6.3 to v3.6.4 on the page, signaling a newer revision tag. This is an administrative update to the page rather than a change to study content or user-facing information.SummaryDifference0.1%

- Check11 days agoNo Change Detected
- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedThe page revision label was updated from v3.6.0 to v3.6.3, indicating an update to the page framework.SummaryDifference0.1%

- Check46 days agoChange DetectedThe revision label at the bottom of the page was updated from v3.5.4 to v3.5.5, indicating a minor update to the page's version metadata. No study content or data appears to have been altered.SummaryDifference0.1%

- Check69 days agoChange DetectedThe page’s revision was updated from v3.5.3 to v3.5.4, indicating a newer build of the entry. This update seems to be a metadata/version change rather than a modification to study details or visible content.SummaryDifference0.1%

- Check90 days agoChange DetectedThe page’s footer revision/version indicator has been updated from v3.5.0 to v3.5.3, reflecting a website/UI release rather than a modification to the study record content.SummaryDifference0.1%

- Check126 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0.SummaryDifference0.1%

Stay in the know with updates to GVAX & Pembrolizumab in MMR-p CRC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the GVAX & Pembrolizumab in MMR-p CRC Clinical Trial page.